Enlivex Secures Financing via Convertible Note with Lind G

Ticker: ENLV · Form: 6-K · Filed: Mar 24, 2026 · CIK: 0001596812

Enlivex Ltd. 6-K Filing Summary
FieldDetail
CompanyEnlivex Ltd. (ENLV)
Form Type6-K
Filed DateMar 24, 2026
Risk Levelmedium
Pages7
Reading Time8 min
Key Dollar Amounts$21.0 million, $19.0 million, $18.7 million, $2.3 million, $3.0 million
Sentimentmixed

Complexity: moderate

Sentiment: mixed

Topics: financing, convertible-debt, security-agreement, capital-raise

TL;DR

**Enlivex just got new funding, but watch out for potential stock dilution.**

AI Summary

Enlivex Ltd. filed a 6-K on March 24, 2026, detailing a Securities Purchase Agreement dated March 23, 2026, with Lind G, which includes a Senior Secured Convertible Promissory Note and a Security Agreement. This indicates Enlivex is securing financing, likely to fund its pharmaceutical operations and research, which is crucial for investors as it impacts the company's financial stability and potential for future growth or dilution.

Why It Matters

This filing reveals Enlivex is raising capital through a convertible note, which could provide necessary funds for its operations but also potentially dilute existing shareholders if the note is converted into stock.

Risk Assessment

Risk Level: medium — The use of a senior secured convertible promissory note introduces both financing and potential dilution risks for existing shareholders.

Analyst Insight

A smart investor would investigate the terms of the Senior Secured Convertible Promissory Note to understand potential dilution and the interest rate, and assess Enlivex's cash burn rate to determine the longevity of this new capital.

Key Players & Entities

  • Enlivex Ltd. (company) — the filer and issuer of the securities
  • Lind G (company) — the counterparty in the Securities Purchase Agreement and Security Agreement
  • March 23, 2026 (date) — date of the Securities Purchase Agreement, Senior Secured Convertible Promissory Note, Security Agreement, and Joinder and First Amendment to Asset Management Agreement
  • March 24, 2026 (date) — filing date and period of report for the 6-K

FAQ

What is the primary purpose of this 6-K filing by Enlivex Ltd.?

The primary purpose of this 6-K filing is to report a Securities Purchase Agreement, a Senior Secured Convertible Promissory Note, and a Security Agreement, all dated March 23, 2026, between Enlivex Ltd. and Lind G, indicating new financing arrangements.

Which specific documents are included in this 6-K filing that relate to the financing deal?

The filing includes the 'SECURITIES PURCHASE AGREEMENT, DATED MARCH 23, 2026, BY AND BETWEEN ENLIVEX LTD.', 'FORM OF SENIOR SECURED CONVERTIBLE PROMISSORY NOTE', and 'SECURITY AGREEMENT, DATED MARCH 23, 2026, BY AND BETWEEN ENLIVEX LTD. AND LIND G'.

Filing Stats: 2,045 words · 8 min read · ~7 pages · Grade level 13.7 · Accepted 2026-03-24 08:34:59

Key Financial Figures

  • $21.0 million — ;) in the aggregate principal amount of $21.0 million in a private placement (the “ Pri
  • $19.0 million — Company an aggregate purchase price of $19.0 million for the Note. After deducing the commit
  • $18.7 million — received net proceeds of approximately $18.7 million before offering expenses. The Note is
  • $2.3 million — e monthly installments of approximately $2.3 million each (the “ Monthly Payment &rdqu
  • $3.0 million — increase the Monthly Payment to either $3.0 million or $5.0 million; provided that no such
  • $5.0 million — nthly Payment to either $3.0 million or $5.0 million; provided that no such increase would i
  • $2.69175 — hares at an initial conversion price of $2.69175 per share, subject to customary adjustm
  • $20 million — are repurchase program to acquire up to $20 million of Ordinary Shares, subject to the sati
  • $0.0033 — ompany’s discretion at a price of $0.0033 per RAIN token at any time prior to Dec

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Enlivex Ltd. (Registrant) By: /s/ Oren Hershkovitz Name: Title: Oren Hershkovitz Chief Executive Officer Date: March 24, 2026 4

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.